Fact CheckerSign in

NCT07556783Completed

Increasing the Use of Self Measured Home Blood Pressure Logs in the Management of Hypertension

Telephone-Based Patient Outreach to Improve Self-Measured Blood Pressure Log Utilization in Chronic Hypertension: A Pragmatic Quality Improvement Randomized Implementation Trial

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

The Telephone-Based Patient Outreach to Improve Home Blood Pressure Monitoring (HBPM) in Chronic Hypertension study is a pragmatic, randomized, open-label quality improvement implementation trial designed to evaluate the effectiveness of a structured telephone outreach intervention in increasing the proportion of patients with chronic hypertension who present to clinic visits with a completed home blood pressure log compared to the receipt of usual primary care services over a 90-day period. The study aims to address the inconsistent integration of HBPM-an evidence-based strategy endorsed by major guidelines to improve diagnostic accuracy and longitudinal management-into routine primary care workflows where no standardized educational or documentation process currently exists. Patients with documented chronic uncontrolled hypertension, defined as three documented readings exceeding 130/80 mmHg, are eligible for participation. Typically, patients at this academic primary care practice lack a standardized process for receiving education on home monitoring or a dedicated mechanism for documenting logs, which can lead to therapeutic inertia and missed opportunities to optimize treatment. The intervention is designed around a structured telephone outreach program led by medical students using a standardized script to provide direct patient education on the clinical value of HBPM and to encourage the completion and presentation of BP logs during subsequent primary care visits.

Status (registry)
Completed
Study type
Interventional
Enrollment
170 (actual)
First submitted
23 Apr 2026
Start date
19 Nov 2025
Primary completion date
8 Apr 2026
Lead sponsor
AdventHealth
NCT number
NCT07556783

What you commit to

  • Study type: Interventional
  • Participants enrolled: 170
  • From 19 Nov 2025 to the primary completion date, 8 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Patients must have a documented diagnosis of chronic uncontrolled hypertension
  • "Uncontrolled" was defined as having three documented blood pressure readings exceeding 130/80 mmHg within the electronic health record.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AdventHealth Winter Park
Coordinator of this site? Confirm its status
OrlandoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.